Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
beta-chloro-D-alanine
pyruvate + ammonia + Cl-
-
loss in enzyme activity during beta-elimination
-
?
beta-phenylalanine + pyruvate
3-oxo-3-phenylpropionic acid + D-alanine
D-2-aminobutanoate + pyruvate
2-oxobutanoate + D-alanine
D-alanine + 2-oxobutanoate
pyruvate + 2-aminobutanoate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
D-alanine + 2-oxoisovalerate
pyruvate + D-valine
-
-
-
?
D-alanine + pyruvate
pyruvate + D-alanine
D-aminobutanoate + 2-oxoglutarate
oxobutanoate + D-glutamate
D-arginine + 2-oxoglutarate
? + D-glutamate
-
6% of the activity with D-alanine
-
?
D-arginine + pyruvate
? + D-alanine
low activity
-
-
?
D-asparagine + 2-oxoglutarate
2-oxosuccinamate + D-glutamate
D-asparagine + pyruvate
2-oxosuccinamate + D-alanine
D-aspartate + 2-oxoglutarate
2-oxosuccinate + D-glutamate
D-aspartate + pyruvate
2-oxosuccinate + D-alanine
D-ethionine + 2-oxoglutarate
4-ethylsulfanyl-2-oxobutanoate + D-glutamate
-
76% of the activity with D-alanine
-
?
D-glutamate + 2-oxobutanoate
2-oxoglutarate + 2-aminobutanoate
D-glutamate + 2-oxoglutarate
2-oxoglutarate + D-glutamate
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
D-glutamine + 2-oxoglutarate
4-carbamoyl-2-oxobutanoate + D-glutamate
D-glutamine + pyruvate
4-carbamoyl-2-oxobutanoate + D-alanine
-
-
-
?
D-histidine + 2-oxoglutarate
3-(1H-imidazol-4-yl)-2-oxopropanoate + L-glutamate
-
6% of the activity with D-alanine
-
?
D-histidine + pyruvate
3-(1H-imidazol-4-yl)-2-oxopropanoate + D-alanine
low activity
-
-
?
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
D-leucine + pyruvate
4-methyl-2-oxopentanoate + D-alanine
low activity
-
-
?
D-lysine + pyruvate
? + D-alanine
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
D-methionine + pyruvate
4-methylsulfanyl-2-oxobutanoate + D-alanine
D-methionine is the best and preferred substrate
-
-
r
D-methionine + pyruvate
4-methylsulfanyl-2-oxobutanoate + L-alanine
D-norleucine + 2-oxoglutarate
2-oxopentanoate + D-glutamate
D-norleucine + pyruvate
2-oxopentanoate + D-alanine
-
-
-
?
D-norvaline + 2-oxoglutarate
2-oxopentanoate + D-glutamate
D-norvaline + pyruvate
2-oxopentanoate + D-alanine
D-ornithine + 2-oxoglutarate
? + D-glutamate
D-ornithine + pyruvate
? + L-alanine
D-phenylalanine + 2-oxoglutarate
phenylpyruvate + D-glutamate
D-phenylalanine + pyruvate
phenylpyruvate + D-alanine
D-serine + 2-oxoglutarate
3-hydroxy-2-oxopropanoate + D-glutamate
D-serine + pyruvate
3-hydroxy-2-oxopropanoate + D-alanine
D-theanine + 2-oxoglutarate
? + D-glutamate
-
40% of the activity with D-alanine
-
?
D-threonine + 2-oxoglutarate
2-oxobutanoate + D-glutamate
-
-
-
r
D-threonine + pyruvate
2-oxobutanoate + D-alanine
very low activity
-
-
?
D-tryptophan + 2-oxoglutarate
3-indole-2-oxopropanoate + D-glutamate
D-tryptophan + pyruvate
3-indole-2-oxopropanoate + D-alanine
D-tyrosine + 2-oxoglutarate
3-(4-hydroxyphenyl)-2-oxopropanoate + D-glutamate
D-valine + 2-oxoglutarate
2-oxoisovalerate + D-glutamate
-
5% of activity with D-alanine
-
?
D-valine + pyruvate
2-oxoisovalerate + D-alanine
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
additional information
?
-
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 74%, enantiomeric excess: 99%
-
-
?
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 68%, enantiomeric excess: 99%
-
-
?
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 8%, enantiomeric excess: 99%
-
-
?
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 17%, enantiomeric excess: 99%
-
-
?
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 3%, enantiomeric excess: 99%
-
-
?
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 6%, enantiomeric excess: 99%
-
-
?
1-(4-nitrophenyl)ethanone + D-alanine
(1R)-1-(4-nitrophenyl)ethanamine + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 59%, enantiomeric excess: 99%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 93%, enantiomeric excess: 99%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 53%, enantiomeric excess: 99%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 30%, enantiomeric excess: 99%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 16%, enantiomeric excess: 99%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 56%, enantiomeric excess: 99%
-
-
?
1-cyclohexylethanone + D-alanine
(1R)-1-cyclohexylethanamine + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 87%, enantiomeric excess: 99%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 39%, enantiomeric excess: 99%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 3%, enantiomeric excess: 99%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 4%, enantiomeric excess: 99%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 42%, enantiomeric excess: 99%
-
-
?
1-phenylethanone + D-alanine
(1R)-1-phenylethanamine + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 94%, enantiomeric excess: 99%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 98%, enantiomeric excess: 99%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 77%, enantiomeric excess: 99%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 6%, enantiomeric excess: 99%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 85%, enantiomeric excess: 99%
-
-
?
4-(3-hydroxy-4-methoxyphenyl)butan-2-one + D-alanine
5-[(3R)-3-aminobutyl]-2-methoxyphenol + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 83%, enantiomeric excess: 99%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 5%, enantiomeric excess: 99%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 71%, enantiomeric excess: 99%
-
-
?
4-(4-hydroxyphenyl)butan-2-one + D-alanine
4-[(3R)-3-aminobutyl]phenol + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 92%, enantiomeric excess: 99%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 20%, enantiomeric excess: 99%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 7%, enantiomeric excess: 99%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 72%, enantiomeric excess: 99%
-
-
?
4-(4-methoxyphenyl)butan-2-one + D-alanine
(2R)-2-amino-4-(4-methoxyphenyl)butane + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 79%, enantiomeric excess: 99%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 64%, enantiomeric excess: 99%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 32%, enantiomeric excess: 99%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 68%, enantiomeric excess: 99%
-
-
?
4-methylpentan-2-one + D-alanine
(2R)-2-amino-4-methylpentane + pyruvate
-
asymmetric synthesis, conversion: 9%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 92%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 32%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 9%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 89%, enantiomeric excess: 99%
-
-
?
4-phenylbutan-2-one + D-alanine
(2R)-2-amino-4-phenylbutane + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
beta-phenylalanine + pyruvate
3-oxo-3-phenylpropionic acid + D-alanine
-
-
-
-
?
beta-phenylalanine + pyruvate
3-oxo-3-phenylpropionic acid + D-alanine
-
-
-
-
?
D-2-aminobutanoate + pyruvate
2-oxobutanoate + D-alanine
-
-
-
r
D-2-aminobutanoate + pyruvate
2-oxobutanoate + D-alanine
-
-
-
?
D-2-aminobutanoate + pyruvate
2-oxobutanoate + D-alanine
-
-
-
?
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
very low activity with: D-histidine, D-phenylalanine, D-arginine and D-lysine, amino acceptors 2-oxoglutarate and pyruvate
-
?
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
D-alanine formation is favoured
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
function of the enzyme is probably the provision of D-amino acids for cell-wall synthesis
-
-
?
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + 2-oxoglutarate
pyruvate + D-glutamate
-
-
-
r
D-alanine + pyruvate
pyruvate + D-alanine
-
-
-
r
D-alanine + pyruvate
pyruvate + D-alanine
-
-
-
?
D-aminobutanoate + 2-oxoglutarate
oxobutanoate + D-glutamate
-
-
-
?
D-aminobutanoate + 2-oxoglutarate
oxobutanoate + D-glutamate
-
97% of the activity with D-alanine
-
?
D-aminobutanoate + 2-oxoglutarate
oxobutanoate + D-glutamate
-
-
-
?
D-asparagine + 2-oxoglutarate
2-oxosuccinamate + D-glutamate
-
38% of activity with D-alanine
-
?
D-asparagine + 2-oxoglutarate
2-oxosuccinamate + D-glutamate
-
-
-
?
D-asparagine + 2-oxoglutarate
2-oxosuccinamate + D-glutamate
-
31% of the activity with D-alanine
-
?
D-asparagine + pyruvate
2-oxosuccinamate + D-alanine
low activity
-
-
?
D-asparagine + pyruvate
2-oxosuccinamate + D-alanine
low activity
-
-
?
D-asparagine + pyruvate
2-oxosuccinamate + D-alanine
-
-
-
?
D-asparagine + pyruvate
2-oxosuccinamate + D-alanine
-
-
-
?
D-asparagine + pyruvate
2-oxosuccinamate + D-alanine
-
-
-
?
D-aspartate + 2-oxoglutarate
2-oxosuccinate + D-glutamate
-
-
-
?
D-aspartate + 2-oxoglutarate
2-oxosuccinate + D-glutamate
-
-
-
r
D-aspartate + 2-oxoglutarate
2-oxosuccinate + D-glutamate
-
-
-
r
D-aspartate + 2-oxoglutarate
2-oxosuccinate + D-glutamate
-
30% of the activity with D-alanine
-
?
D-aspartate + pyruvate
2-oxosuccinate + D-alanine
low activity
-
-
?
D-aspartate + pyruvate
2-oxosuccinate + D-alanine
low activity
-
-
?
D-aspartate + pyruvate
2-oxosuccinate + D-alanine
-
-
-
?
D-aspartate + pyruvate
2-oxosuccinate + D-alanine
-
-
-
?
D-aspartate + pyruvate
2-oxosuccinate + D-alanine
-
-
-
?
D-glutamate + 2-oxobutanoate
2-oxoglutarate + 2-aminobutanoate
-
-
-
?
D-glutamate + 2-oxobutanoate
2-oxoglutarate + 2-aminobutanoate
-
-
-
?
D-glutamate + 2-oxoglutarate
2-oxoglutarate + D-glutamate
-
-
-
?
D-glutamate + 2-oxoglutarate
2-oxoglutarate + D-glutamate
-
-
-
?
D-glutamate + 2-oxoglutarate
2-oxoglutarate + D-glutamate
-
-
-
?
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
high activity
-
-
?
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
high activity
-
-
?
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
-
-
-
r
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
-
-
-
r
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
-
-
-
r
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
-
-
-
r
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
-
-
-
r
D-glutamate + pyruvate
2-oxoglutarate + D-alanine
-
-
-
r
D-glutamine + 2-oxoglutarate
4-carbamoyl-2-oxobutanoate + D-glutamate
-
25% of activity with d-alanine
-
?
D-glutamine + 2-oxoglutarate
4-carbamoyl-2-oxobutanoate + D-glutamate
-
52% of the activity with D-alanine
-
?
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
high activity
-
-
r
D-leucine + 2-oxoglutarate
4-methyl-2-oxopentanoate + D-glutamate
-
8% of the activity with D-alanine
-
?
D-lysine + pyruvate
? + D-alanine
very low activity
-
-
?
D-lysine + pyruvate
? + D-alanine
-
weak activity
-
?
D-lysine + pyruvate
? + D-alanine
-
weak activity
-
?
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
-
30% of activity with d-alanine
-
?
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
-
weak activity
-
?
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
-
-
-
r
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
low activity
-
-
r
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
-
-
-
r
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
low activity
-
-
r
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
-
61% of the activity with D-alanine
-
?
D-methionine + 2-oxoglutarate
4-methylsulfanyl-2-oxobutanoate + D-glutamate
-
weak activity
-
?
D-methionine + pyruvate
4-methylsulfanyl-2-oxobutanoate + L-alanine
-
-
-
?
D-methionine + pyruvate
4-methylsulfanyl-2-oxobutanoate + L-alanine
-
-
-
?
D-methionine + pyruvate
4-methylsulfanyl-2-oxobutanoate + L-alanine
-
-
-
?
D-methionine + pyruvate
4-methylsulfanyl-2-oxobutanoate + L-alanine
-
-
-
?
D-norleucine + 2-oxoglutarate
2-oxopentanoate + D-glutamate
-
7% of activity with D-alanine
-
?
D-norleucine + 2-oxoglutarate
2-oxopentanoate + D-glutamate
-
46% of the activity with D-alanine
-
?
D-norvaline + 2-oxoglutarate
2-oxopentanoate + D-glutamate
-
-
-
?
D-norvaline + 2-oxoglutarate
2-oxopentanoate + D-glutamate
-
83% of the activity with D-alanine
-
?
D-norvaline + pyruvate
2-oxopentanoate + D-alanine
-
-
-
?
D-norvaline + pyruvate
2-oxopentanoate + D-alanine
-
-
-
?
D-ornithine + 2-oxoglutarate
? + D-glutamate
-
65 of activity with D-alanine
-
?
D-ornithine + 2-oxoglutarate
? + D-glutamate
-
weak activity
-
?
D-ornithine + 2-oxoglutarate
? + D-glutamate
-
16% of activity with D-alanine
-
?
D-ornithine + pyruvate
? + L-alanine
-
-
-
?
D-ornithine + pyruvate
? + L-alanine
-
-
-
?
D-ornithine + pyruvate
? + L-alanine
-
-
-
?
D-phenylalanine + 2-oxoglutarate
phenylpyruvate + D-glutamate
-
-
-
r
D-phenylalanine + 2-oxoglutarate
phenylpyruvate + D-glutamate
-
32% of the activity with D-alanine
-
?
D-phenylalanine + 2-oxoglutarate
phenylpyruvate + D-glutamate
-
-
-
?
D-phenylalanine + pyruvate
phenylpyruvate + D-alanine
high activity
-
-
?
D-phenylalanine + pyruvate
phenylpyruvate + D-alanine
-
-
-
?
D-phenylalanine + pyruvate
phenylpyruvate + D-alanine
-
weak activity
-
?
D-serine + 2-oxoglutarate
3-hydroxy-2-oxopropanoate + D-glutamate
-
8% of activity with d-alanine
-
?
D-serine + 2-oxoglutarate
3-hydroxy-2-oxopropanoate + D-glutamate
-
weak activity
-
?
D-serine + 2-oxoglutarate
3-hydroxy-2-oxopropanoate + D-glutamate
-
-
-
r
D-serine + 2-oxoglutarate
3-hydroxy-2-oxopropanoate + D-glutamate
best substrate
-
-
r
D-serine + pyruvate
3-hydroxy-2-oxopropanoate + D-alanine
low activity
-
-
?
D-serine + pyruvate
3-hydroxy-2-oxopropanoate + D-alanine
-
-
-
?
D-tryptophan + 2-oxoglutarate
3-indole-2-oxopropanoate + D-glutamate
-
4% of the activity with D-alanine
-
?
D-tryptophan + 2-oxoglutarate
3-indole-2-oxopropanoate + D-glutamate
-
-
-
?
D-tryptophan + pyruvate
3-indole-2-oxopropanoate + D-alanine
moderate activity
-
-
?
D-tryptophan + pyruvate
3-indole-2-oxopropanoate + D-alanine
-
weak activity
-
?
D-tryptophan + pyruvate
3-indole-2-oxopropanoate + D-alanine
-
-
-
?
D-tyrosine + 2-oxoglutarate
3-(4-hydroxyphenyl)-2-oxopropanoate + D-glutamate
-
-
-
r
D-tyrosine + 2-oxoglutarate
3-(4-hydroxyphenyl)-2-oxopropanoate + D-glutamate
low activity
-
-
r
D-valine + pyruvate
2-oxoisovalerate + D-alanine
low activity
-
-
?
D-valine + pyruvate
2-oxoisovalerate + D-alanine
-
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 43%, enantiomeric excess: 99%
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 69%, enantiomeric excess: 99%
-
-
?
heptan-2-one + D-alanine
(2R)-2-aminoheptane + pyruvate
-
asymmetric synthesis, conversion: 15%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 14%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 88%, enantiomeric excess: 99%
-
-
?
hexan-2-one + D-alanine
(2R)-2-aminohexane + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 77%, enantiomeric excess: 99%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 23%, enantiomeric excess: 99%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 65%, enantiomeric excess: 99%
-
-
?
nonan-2-one + D-alanine
(2R)-2-aminononane + pyruvate
-
asymmetric synthesis, conversion: 12%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 99%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 92%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 47%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 30%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 66%, enantiomeric excess: 99%
-
-
?
pentan-2-one + D-alanine
(2R)-2-aminopentane + pyruvate
-
asymmetric synthesis, conversion: 1%
-
-
?
additional information
?
-
substrate specificity of enzyme AtDAT1, no or alomost no activity with D-Pro and D-Tyr, respectively
-
-
-
additional information
?
-
-
substrate specificity of enzyme AtDAT1, no or alomost no activity with D-Pro and D-Tyr, respectively
-
-
-
additional information
?
-
substrate specificity of enzyme AtDAT1, no or alomost no activity with D-Pro and D-Tyr, respectively
-
-
-
additional information
?
-
comparison of the active sites of Dret with D- and L-leucine in presence of PLP, overview. The absence of the Arg98* residue, that is conservative for the DAATs in the active site of Dret, is presumably compensated by the Arg54* residue, the functional group occupies the same spatial position as the Arg98* functional group in the bsDAAT. This residue forms two stable hydrogen bonds with D-leucine in the enzyme-substrate complex. In the case of L-leucine, only one of the two bonds is preserved, and a new hydrogen bond is formed between the alpha-COO- group of L-leucine and His53*. This leads to the disruption of the structure of the active site and explains the absence of a reaction with L-leucine. The binding of D-leucine by the residues of the active site of Dret promotes efficient transformations of the substrate by the mechanism determined for transaminases
-
-
-
additional information
?
-
comparison of the active sites of Dret with D- and L-leucine in presence of PLP, overview. The absence of the Arg98* residue, that is conservative for the DAATs in the active site of Dret, is presumably compensated by the Arg54* residue, the functional group occupies the same spatial position as the Arg98* functional group in the bsDAAT. This residue forms two stable hydrogen bonds with D-leucine in the enzyme-substrate complex. In the case of L-leucine, only one of the two bonds is preserved, and a new hydrogen bond is formed between the alpha-COO- group of L-leucine and His53*. This leads to the disruption of the structure of the active site and explains the absence of a reaction with L-leucine. The binding of D-leucine by the residues of the active site of Dret promotes efficient transformations of the substrate by the mechanism determined for transaminases
-
-
-
additional information
?
-
comparison of the active sites of Dret with D- and L-leucine in presence of PLP, overview. The absence of the Arg98* residue, that is conservative for the DAATs in the active site of Dret, is presumably compensated by the Arg54* residue, the functional group occupies the same spatial position as the Arg98* functional group in the bsDAAT. This residue forms two stable hydrogen bonds with D-leucine in the enzyme-substrate complex. In the case of L-leucine, only one of the two bonds is preserved, and a new hydrogen bond is formed between the alpha-COO- group of L-leucine and His53*. This leads to the disruption of the structure of the active site and explains the absence of a reaction with L-leucine. The binding of D-leucine by the residues of the active site of Dret promotes efficient transformations of the substrate by the mechanism determined for transaminases
-
-
-
additional information
?
-
comparison of the active sites of Dret with D- and L-leucine in presence of PLP, overview. The absence of the Arg98* residue, that is conservative for the DAATs in the active site of Dret, is presumably compensated by the Arg54* residue, the functional group occupies the same spatial position as the Arg98* functional group in the bsDAAT. This residue forms two stable hydrogen bonds with D-leucine in the enzyme-substrate complex. In the case of L-leucine, only one of the two bonds is preserved, and a new hydrogen bond is formed between the alpha-COO- group of L-leucine and His53*. This leads to the disruption of the structure of the active site and explains the absence of a reaction with L-leucine. The binding of D-leucine by the residues of the active site of Dret promotes efficient transformations of the substrate by the mechanism determined for transaminases
-
-
-
additional information
?
-
comparison of the active sites of Dret with D- and L-leucine in presence of PLP, overview. The absence of the Arg98* residue, that is conservative for the DAATs in the active site of Dret, is presumably compensated by the Arg54* residue, the functional group occupies the same spatial position as the Arg98* functional group in the bsDAAT. This residue forms two stable hydrogen bonds with D-leucine in the enzyme-substrate complex. In the case of L-leucine, only one of the two bonds is preserved, and a new hydrogen bond is formed between the alpha-COO- group of L-leucine and His53*. This leads to the disruption of the structure of the active site and explains the absence of a reaction with L-leucine. The binding of D-leucine by the residues of the active site of Dret promotes efficient transformations of the substrate by the mechanism determined for transaminases
-
-
-
additional information
?
-
in vivo substrate specificity of strain SM1922
-
-
-
additional information
?
-
in vivo substrate specificity of strain SM1922
-
-
-
additional information
?
-
-
enzyme is specific for beta-phenylalanine and its derivatives as the amino donor. It catalyzes the resolution of racemic beta-phenylalanine and its derivatives, the products (R)-amino acids are obtained with about 50% conversions and 99% ee
-
-
?
additional information
?
-
-
enzyme is specific for beta-phenylalanine and its derivatives as the amino donor. It catalyzes the resolution of racemic beta-phenylalanine and its derivatives, the products (R)-amino acids are obtained with about 50% conversions and 99% ee
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Martinez-Carrion, M.; Jenkins, W.T.
D-Alanine-D-glutamate transaminase. I. Purification and characterization
J. Biol. Chem.
240
3538-3546
1965
Bacillus subtilis
brenda
Martinez-Carrion, M.; Jenkins, W.T.
D-Alanine-D-glutamate transaminase. II. Inhibitors and the mechanism of transamination of D-amino acids
J. Biol. Chem.
240
3547-3552
1965
Bacillus subtilis
brenda
Ogawa, T.; Fukuda, M.
Occurrence of D-amino acid aminotransferase in pea seedlings
Biochem. Biophys. Res. Commun.
52
998-1002
1973
Pisum sativum
brenda
Soper, T.S.; Jones, W.M.; Lerner, B.; Trop, M.; Manning, J.M.
Inactivation of bacterial D-amino acid transaminase by beta-chloro-D-alanine
J. Biol. Chem.
252
3170-3175
1977
Lysinibacillus sphaericus
brenda
Soper, T.S.; Manning, J.M.; Marcotte, P.A.; Walsh, C.T.
Inactivation of bacterial D-amino acid transaminases by the olefinic amino acid D-vinylglycine
J. Biol. Chem.
252
1571-1575
1977
Bacillus subtilis, Lysinibacillus sphaericus
brenda
Gosling, J.P.; Fottrell, P.F.
The partial purification and some properties of D-alanine aminotransferase from Rhizobium japonicum
Biochem. Soc. Trans.
1
252-254
1973
Bradyrhizobium japonicum
-
brenda
Yonaha, K.; Misono, H.; Yamamoto, T.; Soda, K.
D-amino acid aminotransferase of Bacillus sphaericus. Enzymologic and spectrometric properties
J. Biol. Chem.
250
6983-6989
1975
Lysinibacillus sphaericus
brenda
Kishimoto, K.; Yoshimura, T.; Esaki, N.; Sugio, S.; Manning, J.M.; Soda, K.
Role of leucine 201 of thermostable D-amino acid aminotransferase from a thermophile, Bacillus sp. YM-1
J. Biochem.
117
691-696
1995
Bacillus sp. (in: Bacteria), Bacillus sp. (in: Bacteria) YM-1
brenda
Sugio, S.; Petsko, G.A.; Manning, J.M.; Soda, K.; Ringe, D.
Crystal structure of a D-amino acid aminotransferase: how the protein controls stereoselectivity
Biochemistry
34
9661-9669
1995
Bacillus sp. (in: Bacteria), Lysinibacillus sphaericus
brenda
Ro, H.S.; Hong, S.P.; Seo, H.J.; Yoshimura, T.; Esaki, N.; Soda, K.; Kim, H.S.; Sung, M.H.
Site-directed mutagenesis of the amino acid residues in beta-strand III [Val30-Val36] of D-amino acid aminotransferase of Bacillus sp. YM-1
FEBS Lett.
398
141-145
1996
Bacillus sp. (in: Bacteria)
brenda
Fuchikami, Y.; Yoshimura, T.; Gutierrez, A.; Soda, K.; Esaki, N.
Construction and properties of a fragmentary D-amino acid aminotransferase
J. Biochem.
124
905-910
1998
Bacillus sp. (in: Bacteria)
brenda
Gutierrez, A.; Yoshimura, T.; Fuchikami, Y.; Soda, K.; Esaki, N.
A mutant D-amino acid aminotransferase with broad substrate specificity: construction by replacement of the interdomain loop Pro119-Arg120-Pro121 by Gly-Gly-Gly
Protein Eng.
11
53-58
1998
Bacillus sp. (in: Bacteria)
brenda
Sugio, S.; Kashima, A.; Kishimoto, K.; Peisach, D.; Petsko, G.A.; Ringe, D.; Yoshimura, T.; Esaki, N.
Crystal structures of L201A mutant of D-amino acid aminotransferase at 2.0 A resolution: implication of the structural role of Leu201 in transamination
Protein Eng.
11
613-619
1998
Bacillus sp. (in: Bacteria)
brenda
Peisach, D.; Chipman, D.M.; Van Ophem, P.W.; Manning, J.M.; Ringe, D.
Crystallographic study of steps along the reaction pathway of D-amino acid aminotransferase
Biochemistry
37
4958-4967
1998
Bacillus sp. (in: Bacteria) (P19938), Bacillus sp. (in: Bacteria)
brenda
Gutierrez, A.; Yoshimura, T.; Fuchikami, Y.; Esaki, N.
Modulation of activity and substrate specificity by modifying the backbone length of the distant interdomain loop of D-amino acid aminotransferase
Eur. J. Biochem.
267
7218-7223
2000
Bacillus sp. (in: Bacteria)
brenda
Ro, H.S.
Effects of salts on the conformation and catalytic properties of D-amino acid aminotransferase
J. Biochem. Mol. Biol.
35
306-312
2002
Bacillus sp. (in: Bacteria)
brenda
Schtzle, S.; Steffen-Munsberg, F.; Thontowi, A.; Hhne, M.; Robins, K.; Bornscheuer, U.
Enzymatic asymmetric synthesis of enantiomerically pure aliphatic, aromatic and arylaliphatic amines with (R)-selective amine transaminases
Adv. Synth. Catal.
353
2439-2445
2011
Aspergillus fischeri, Aspergillus fumigatus, Aspergillus oryzae, Aspergillus terreus, Fusarium graminearum, Penicillium chrysogenum, Mycolicibacterium vanbaalenii
-
brenda
Du, Y.; Dong, W.; Jiang, J.; Chen, Q.; Feng, J.; Wu, Q.; Zhu, D.
[Expression and characterization of a novel ?-transaminase from Burkholderia phytofirmans PsJN].
Sheng Wu Gong Cheng Xue Bao
32
912-926
2016
Paraburkholderia phytofirmans, Paraburkholderia phytofirmans PsJN
brenda
Mortuza, R.; Aung, H.L.; Taiaroa, G.; Opel-Reading, H.K.; Kleffmann, T.; Cook, G.M.; Krause, K.L.
Overexpression of a newly identified D-amino acid transaminase in Mycobacterium smegmatis complements glutamate racemase deletion
Mol. Microbiol.
107
198-213
2018
Mycolicibacterium smegmatis (A0R4D5), Mycolicibacterium smegmatis, Mycolicibacterium smegmatis mc2155 (A0R4D5)
brenda
Voss, M.; Xiang, C.; Esque, J.; Nobili, A.; Menke, M.J.; Andre, I.; Hoehne, M.; Bornscheuer, U.T.
Creation of (R)-amine transaminase activity within an alpha-amino acid transaminase scaffold
ACS Chem. Biol.
15
416-424
2020
Bacillus sp. (in: Bacteria) (P19938), Bacillus sp. (in: Bacteria) YM-1 (P19938)
brenda
Yu, Y.; Yang, J.; Zheng, L.; Sheng, Q.; Li, C.; Wang, M.; Zhang, X.; McMinn, A.; Zhang, Y.; Song, X.; Chen, X.
Diversity of D-amino acid utilizing bacteria from Kongsfjorden, Arctic, and the metabolic pathways for seven D-amino acids
Front. Microbiol.
10
2983
2020
Halomonas titanicae (A0A558JDR6), Halomonas titanicae SM1922 (A0A558JDR6)
brenda
Suarez, J.; Hener, C.; Lehnhardt, V.A.; Hummel, S.; Stahl, M.; Kolukisaoglu, U.e.
AtDAT1 is a key enzyme of D-amino acid stimulated ethylene production in Arabidopsis thaliana
Front. Plant Sci.
10
1609
2019
Arabidopsis thaliana (Q8L493), Arabidopsis thaliana, Arabidopsis thaliana Col-0 (Q8L493)
brenda
Khrenova, M.; Zavyalova, S.; Bezsudnova, E.
Molecular mechanism of stereospecificity toward D-leucine of the transaminase from Desulfohalobium retbaense revealed by molecular dynamic simulations
Moscow Univ. Chem. Bull.
75
167-171
2020
Desulfohalobium retbaense (C8X272), Desulfohalobium retbaense ATCC 49708 (C8X272), Desulfohalobium retbaense DSM 5692 (C8X272), Desulfohalobium retbaense HR100 (C8X272), Desulfohalobium retbaense JCM 16813 (C8X272)
-
brenda